NVS Novartis AG Earnings and EPS analysis

EPS in 2026 (TTM): $5.25

Last Report Period Date: Sep 30, 2026

As of November 2026, according to Novartis AG's latest financial report, the company's current EPS (TTM) is $5.25. In 2025, the company recorded an earnings per share (EPS) of $7.21, which represents an increase compared to its EPS of $5.92 in 2024. Novartis AG's earnings per share for the quarterly report ending on Sep 30, 2026 was $0.63.

The annual EPS in 2025 was $7.21, an increase of 21.8% from $5.92 in 2024. For the quarter ending Sep 30, 2026, the EPS was $0.63, showing a 69.1% decrease from the same quarter last year. The trailing twelve months (TTM) EPS as of September 2026 is $5.25. In 2024, the annual EPS was $5.92, showing a decrease of 17.2% from 2023.

Over the last 12 months, Novartis AG has registered an EPS growth of -69.1% (YoY, quarterly). Looking at a longer timeframe, the company recorded an average EPS growth rate of 31.2% per year over the past 3 years. Over the last 5 years, the company had an average EPS growth rate of 15.2%. A 10-year view shows that NVS has seen an average EPS growth of -0.3% per year.